User profiles for Giuliano Rizzardini
 | giuliano rizzardiniospedale fatebenefratelli-sacco milano Verified email at asst-fbf-sacco.it Cited by 22659 |
Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study
…, C Gervasoni, AL Ridolfo, G Rizzardini… - Clinical infectious …, 2020 - academic.oup.com
To the Editor—We read with interest the article by Wang et al [1] describing the clinical
features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT …
…, A Lazzarin, G Rizzardini… - Clinical Infectious …, 2010 - academic.oup.com
Background. Abacavir-lamivudine and tenofovir DF-emtricitabine fixed-dose combinations
are commonly used as first-line antiretroviral therapies. However, few studies have …
are commonly used as first-line antiretroviral therapies. However, few studies have …
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel
…, JA Aberg, P Cahn, JSG Montaner, G Rizzardini… - Jama, 2010 - jamanetwork.com
Context Recent data regarding the consequences of untreated human immunodeficiency
virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and …
virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and …
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel
…, SM Hammer, P Reiss, DD Richman, G Rizzardini… - Jama, 2012 - jamanetwork.com
Context New trial data and drug regimens that have become available in the last 2 years
warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency …
warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency …
[HTML][HTML] ABT-450/r–ombitasvir and dasabuvir with or without ribavirin for HCV
…, V Chulanov, E Janczewska, G Rizzardini… - … England Journal of …, 2014 - Mass Medical Soc
Background The interferon-free regimen of ABT-450 with ritonavir (ABT-450/r), ombitasvir,
and dasabuvir with or without ribavirin has shown efficacy in inducing a sustained virologic …
and dasabuvir with or without ribavirin has shown efficacy in inducing a sustained virologic …
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
…, D Marotto, S Ardizzone, G Rizzardini… - Clinical and …, 2020 - europepmc.org
A severe outbreak of coronavirus disease 2019 (COVID-19) emerged in China in December
2019, and spread so rapidly that more than 200,000 cases have so far been reported …
2019, and spread so rapidly that more than 200,000 cases have so far been reported …
[HTML][HTML] Retinal findings in patients with COVID-19: Results from the SERPICO-19 study
…, M Oldani, S Marini, P Villa, G Rizzardini… - …, 2020 - thelancet.com
Background Coronavirus disease 2019 (COVID-19) has been associated to microvascular
alterations. We screened the fundus of patients with COVID-19 to detect alterations of the …
alterations. We screened the fundus of patients with COVID-19 to detect alterations of the …
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study
…, M Piscaglia, M Coen, G Gubertini, G Rizzardini… - Pharmacological …, 2020 - Elsevier
Italy was the first European country hit by the COVID-19 pandemic and has the highest number
of recorded COVID-19 deaths in Europe. This prospective cohort study of the correlates …
of recorded COVID-19 deaths in Europe. This prospective cohort study of the correlates …
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label …
ET Overton, G Richmond, G Rizzardini, H Jaeger… - The Lancet, 2020 - thelancet.com
Background Phase 3 clinical studies showed non-inferiority of long-acting intramuscular
cabotegravir and rilpivirine dosed every 4 weeks to oral antiretroviral therapy. Important phase 2 …
cabotegravir and rilpivirine dosed every 4 weeks to oral antiretroviral therapy. Important phase 2 …
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and …
Background Effective two-drug regimens could decrease long-term drug exposure and toxicity
with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and …
with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and …
